Doctor’s Passport

Find your next topic

Explore the current textbook

Available drafts · Clinical review pending
Membership
Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.
RapidMSRAMRCGP

Men's health in primary care

Essential points for quick revision.

Saved on this device

Synopsis

Address urinary, sexual, reproductive, cardiovascular and mental-health concerns using symptom-led assessment, informed screening decisions and attention to barriers that delay help seeking.

  • Use inclusive, anatomy-based care: prostate, testes and pregnancy potential cannot be inferred reliably from identity alone.
  • Acute testicular pain is torsion until assessed; sudden onset, high-riding testis or nausea requires immediate surgical evaluation without delaying for routine ultrasound.
  • Lower urinary tract symptoms require distinction among storage, voiding and post-micturition symptoms plus infection, retention, neurological disease and cancer warning features.

Key red flags

Testicular torsion

Sudden unilateral scrotal pain with nausea, abnormal lie or marked tenderness needs immediate surgical assessment; delay threatens viability.

Acute urinary retention

Painful inability to void with a palpable bladder needs prompt decompression and cause assessment, with escalation for sepsis, renal or neurological features.

Reasoning priorities

01
Urinalysis

Look for blood, infection indicators, glycosuria and protein in LUTS.

Relate to symptoms and send or repeat tests when indicated; a normal dip does not close a persistent haematuria concern.

Worked reasoning

Worked case: PSA request at 58Separate informed testing from population screening

A well 58-year-old without urinary symptoms asks for a PSA because a friend was diagnosed with prostate cancer.

  1. Clarify symptoms, ancestry, family history, known pathogenic variants, medicines, infection or instrumentation and what the person expects the test to achieve.
  2. Reason that population screening is not recommended; determine whether the narrow current BRCA2-plus-family-history targeted recommendation or a symptomatic pathway applies, and explain PSA false results, overdiagnosis and downstream MRI or biopsy.
  3. Reach the final action through informed choice: do not call PSA a routine MOT; arrange testing only after counselling if appropriate, or document informed deferral, with current local eligibility checked.
  4. Verify that the result will be reviewed by a named clinician, give symptom safety netting and record the discussion, risk factors and agreed threshold-dependent next step.
Open full textbook Answer 2 questions
Sources and review status5 sources · checked 7 Sept 2026 · clinical review pending
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Apply principles in context and verify current guidance when a decision affects care. Source check completed 7 Sept 2026; clinical approval remains outstanding.

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom